Make your own free website on Tripod.com

HPV Vaccine
Home
Facts
Controversy
Links
About the Author
Overview of the HPV Vaccine

Approved by the U.S. Food and Drug Administration in June 2006, the HPC vaccine is hailed by the science community as a huge step forward in reducing suffering and deaths from cervical cancer in women.

  • This vaccine is the first of its kind in preventing common HPV strains that have been linked to certain types of cancers
  • Certain religious viewpoints on the vaccine have made distribution of the vaccine a controversial subject
  • While this vaccine is designed to prevent cervical cancer in women, studies are being done to determine whether or not the vaccine is effective on men, who can develop penile and anal cancer from HPV
  • Studies predict that vaccinating both sexes will dramatically reduce the rate of infection within a population

Site last updated on August 5, 2006